3rd Viral Vector Process Development & Manufacturing Summit 2025

 

The 3rd Viral Vector Process Development & Manufacturing Summit returns to Boston, bringing together industry leaders from Sanofi, Kite, Ultragenyx, and more to revolutionize viral vector production for cell and gene therapies.

With over 800 candidates in clinical trials and recent BLA approvals from Adaptimmune, bluebird bio, and Pfizer, 2024 marks a pivotal year for scalable, cost-effective manufacturing. This premier event features talks, panels, and workshops on yield optimization, purification advancements, scale-up, and regulatory updates.

Don’t miss this opportunity to explore cutting-edge innovations and collaborate with experts driving the future of AAV, AV, and LV process development.

More Info

---

---